Biomerica (NASDAQ:BMRA) Stock Passes Above Two Hundred Day Moving Average – Time to Sell?

Shares of Biomerica, Inc. (NASDAQ:BMRA) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.36 and traded as high as $0.56. Biomerica shares last traded at $0.51, with a volume of 1,455,581 shares trading hands.

Biomerica Trading Up 14.7 %

The company has a 50 day moving average of $0.40 and a 200 day moving average of $0.36. The firm has a market cap of $9.28 million, a price-to-earnings ratio of -1.49 and a beta of -0.98.

Biomerica (NASDAQ:BMRA) last announced its quarterly earnings results on Tuesday, January 14th. The company reported ($0.06) EPS for the quarter. Biomerica had a negative net margin of 100.52% and a negative return on equity of 90.19%.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.